WebDec 27, 2012 · Cofactor Genomics Oct 2012 - Sep 20249 years Greater St. Louis Area Cofactor Genomics uses RNA to diagnose disease. Our … WebSep 8, 2024 · Cofactor Genomics is on a mission to close the Precision Medicine Gap through Predictive Immune Modeling. Cofactor has leveraged its experience as one of the first CAP-certified, clinical RNA sequencing laboratories to develop new methods that accurately and holistically characterize disease. Instead of searching for isolated, single …
Cofactor Genomics Commences First Predictive Immune Modeling …
WebFeb 27, 2024 · SCOTTSDALE, Ariz. -- February 27, 2024 -- Cofactor Genomics, the company bridging the precision medicine gap with Predictive Immune Modeling, today announced preliminary results from a collaborative study with Washington University School of Medicine in St. Louis, which demonstrated the superior performance of the company’s … WebCofactor Genomics is developing diagnostics that predict patient response to immunotherapy. Using the power of RNA and machine learning, Cofactor’s diagnostics’ … Cofactor’s technology is protected by United States Patent #20240227138. We have … Jarret Glasscock, PhD, CEO of Cofactor Genomics explains how diagnostics are … We use both our own and third-party cookies for statistical purposes and to … Disease is complex. We’re building tools to better characterize diseases like cancer … Cofactor Genomics Cements Clinical Diagnostic Plans as Immunotherapy … How to use Cofactor's T Cell Subtype Profiling (TCSP) Portal. Cofactor … Immune Modeling Analysis Reveals Immunologic Signatures Associated … Readout from the national PREDAPT multicenter clinical trial presented at … Wired covers Cofactor Genomics! Thanks to Nick Stockton for spending some time … chowchilla ca flooding
Cofactor Genomics Raises $18M in Series A Financing
WebFeb 16, 2024 · Cofactor Genomics RNA-seq Assay Outperforms PD-L1 IHC to Predict Immunotherapy Responders Premium The firm is aiming to commercialize its OncoPrism assay in 2024 as a laboratory-developed test to identify head and neck cancer patients eligible for checkpoint inhibitors. WebApr 13, 2024 · Cofactor Genomics is on a mission to close the Precision Medicine Gap through Predictive Immune Modeling. Cofactor has leveraged its experience as one of the first CAP-certified, clinical RNA sequencing laboratories to develop new methods that accurately and holistically characterize disease. Instead of searching for isolated, single … WebMar 25, 2014 · In 2009, I was one of the founders of Cofactor Genomics, a predictive immune modeling company, that builds diagnostics for … genflow biosci - ord gbp0.0003